Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

Contributed by: PR Newswire

Tags

VENUS-MEDTECH

More Like This

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

PR Newswire associated0

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

PR Newswire associated0

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

Court Sides with Cardiovalve in Edwards patent spat

PR Newswire associated0

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024